Results 191 to 200 of about 145,853 (310)

471 ISOLATED INTESTINAL BILE ACID (BA) MALABSORPTION, A CAUSE OF CHRONIC DIARRHEA [PDF]

open access: bronze, 1978
Judith M. Sondheimer   +4 more
openalex   +1 more source

Effects of Betaine on Performance, Blood Biochemistry, Nutrient Utilization and Gut Health in Coccidia‐Infected Broilers

open access: yesVeterinary Medicine and Science, Volume 12, Issue 1, January 2026.
Betaine supplementation improved growth performance, nutrient digestibility, blood lipid profiles and caecal lesion scores in broilers experimentally challenged with coccidiosis, with the greatest benefits observed at 600 mg/kg, highlighting its potential as a supportive dietary strategy against coccidial infection. ABSTRACT The objective of this study
Abdul Hafeez   +6 more
wiley   +1 more source

Cremation weights for an Italian contemporary sample

open access: yesJournal of Forensic Sciences, Volume 71, Issue 1, Page 516-524, January 2026.
Abstract The increased demand for the study of cremated remains, combined with their poor state of preservation, presents anthropologists with highly complex and challenging cases. In this context, cremains weight is considered a stable parameter, not influenced by the fragmentation state of the remains, useful in anthropological investigations ...
Barbara Bertoglio   +7 more
wiley   +1 more source

Malnutrition and Sarcopenia in Patients with Neuroendocrine Tumors: A Comprehensive Review of Evidence. [PDF]

open access: yesBiomolecules
Poulia KA   +5 more
europepmc   +1 more source

Associations Between Vitamin D Status and Clinical Presentation Among French Inpatients With Substance Use Disorders

open access: yesAddiction Biology, Volume 31, Issue 1, January 2026.
Nine out of ten inpatients treated for various types of substance use disorders had a Vitamin D deficiency. Vitamin D deficiency was associated with lower calcium plasma levels, higher BMI and craving levels for both substance and food. Vitamin D supplementation should be part of the treatment regimen of people with substance use disorders.
Luca Pavirani   +5 more
wiley   +1 more source

Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 112-121, January 2026.
Abstract Aims Semaglutide, a GLP‐1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The SEMALEAN study aims to evaluate these parameters in patients with obesity treated with Semaglutide (2.4 mg).
Mathieu Alissou   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy